Vensana Capital
Overview
Vensana Capital is a venture capital and growth equity investment firm dedicated to partnering with entrepreneurs who seek to transform healthcare with breakthrough innovations in medical technology . Launched in 2019, Vensana is actively investing in development and commercial stage companies across the medtech sector, including medical devices, data science-oriented solutions, life science tools & diagnostics, and tech-enabled services .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| SpyGlass Pharma | Feb 2026 | IPO | Co-investor |
| Ventaris Surgical | Jan 2026 | Series A | Co-investor |
| Apella Technology | Jan 2026 | Series B | Co-investor |
| Okami Medical | Nov 2025 | Early Funding | Co-investor |
| Luna Diabetes | Aug 2025 | Series A | Lead |
Key People
Justin Klein
Co-Founder Managing Partner
Kirk Nielsen
Co-Founder Managing Partner
Bill Hoffman
Venture Partner
Ross D. Segan
Venture Partner
Amrinder Singh
Partner
Greg Banker
Partner
Maria Berkman
Partner
Mike Kramer
Partner
Steve Schwen
Partner and Chief Financial Officer
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
